Philogen announces its attendance at the Peptide Therapeutic Forum 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Small Molecule Therapeutics as an alternative...
Read moreDario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology indications”. Dario Neri is giving a talk on “intra-cork”...
Read morePhilogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled “Non-internalizing Small Molecule-Drug Conjugates and...
Read morePhilogen announces its attendance at the workshop “Il Sistema Ricerca-Industria in Italia” at Accademia dei Lincei (Rome, Italy). Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From...
Read moreDario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
Philogen is presenting a ePoster entitled “A novel tumor-targeting cytokine-based therapy in combination with lomustine displays promising anti-tumor activity against glioblastoma” Please follow the link below for more information WFNOS...
Read more